This compound is a sulfonamide derivative containing a pyrazole ring substituted with a trifluoromethyl group and a methylphenyl group. It is identified as an impurity associated with an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 170570-01-1
Celecoxib
pharmaceutical raw material
Aprepitant
pharmaceutical raw material
Ipamorelin
pharmaceutical raw material
Doxycycline monohydrate
pharmaceutical raw material
Roblitinib
pharmaceutical raw material
2,5-Dimethylcelecoxib
pharmaceutical raw material
Mavacoxib
pharmaceutical raw material
4-Desmethyl-2-methyl Celecoxib
pharmaceutical intermediate
4-[5-(3-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
MPVPOTMPKLOUHZ-UHFFFAOYSA-N
CC1=CC(=CC=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F